Published in Cancer on June 15, 1996
Primary angiosarcomas of the breast. Cancer (2007) 1.54
Radiation-induced sarcoma of the breast: a systematic review. Oncologist (2012) 1.05
Radiation-induced complications after breast cancer radiation therapy: a pictorial review of multimodality imaging findings. Korean J Radiol (2009) 0.98
Should cancer survivors fear radiation-induced sarcomas? Sarcoma (1997) 0.94
Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute. World J Surg (2011) 0.83
A vinyl chloride-exposed worker with an adrenal gland angiosarcoma: a case report. Ind Health (2013) 0.81
Long-term survival of a patient with scalp angiosarcoma and multiple metastases treated using combination therapy: A case report. Oncol Lett (2015) 0.81
Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature. Cancer (1997) 0.79
Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review. Curr Opin Oncol (2012) 0.79
Imaging features of soft tissue epithelioid angiosarcoma in the lower extremity: A case report. Oncol Lett (2016) 0.75
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol (2010) 5.91
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med (1992) 3.21
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol (1997) 2.41
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 1.80
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol (2009) 1.57
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience. Eur J Cancer (1991) 1.39
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol (2006) 1.29
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma. Ann Oncol (2013) 1.20
Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol (1994) 1.16
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. Br J Cancer (2007) 1.15
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically. Br J Cancer (1994) 1.15
Characterization of ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer (1999) 1.13
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. Br J Cancer (2013) 1.06
Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol (2001) 1.05
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Res Treat (1997) 1.05
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. J Clin Oncol (1986) 1.04
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol (1989) 1.04
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res (2012) 1.03
First-line single-agent cetuximab in patients with advanced colorectal cancer. Ann Oncol (2007) 1.01
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol (1998) 1.00
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol (2005) 0.98
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res (2008) 0.96
High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer (2001) 0.95
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer (1991) 0.95
Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori (2000) 0.94
Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer. J Clin Oncol (1997) 0.91
Perianal Paget's disease: case report of an elderly patient treated with polychemotherapy and radiotherapy. Tumori (1984) 0.89
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer. J Clin Oncol (1996) 0.88
[Lipoma of the tongue. A clinical case report]. Minerva Stomatol (1992) 0.88
Long-term femoral vein central venous access in cancer patients. Eur J Surg Oncol (1996) 0.88
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer. Eur J Cancer (1993) 0.87
UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993. Int J Cancer (1994) 0.87
Cancer in the elderly: assessing patients for fitness. Crit Rev Oncol Hematol (2000) 0.86
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. Clin Cancer Res (1995) 0.86
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer. Br J Cancer (1994) 0.85
Multifocal ischemic necrosis of bone in scleroderma. Clin Rheumatol (1991) 0.85
Adjuvant immunochemotherapy in colorectal cancer Dukes C. Oncology (1987) 0.84
INK4/ARF germline alterations in pancreatic cancer patients. Ann Oncol (2004) 0.83
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG. Ann Oncol (2005) 0.83
Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol (1998) 0.83
Molecular characterization of an Italian series of sporadic GISTs. Gastric Cancer (2013) 0.83
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil. Cancer Chemother Pharmacol (1993) 0.83
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol (1998) 0.83
Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. Eur J Surg Oncol (1995) 0.82
Immediate reconstruction of the penis using an inferiorly based rectus abdominis myocutaneous flap. Plast Reconstr Surg (1988) 0.82
[The role of the general practitioner and dentist in the early diagnosis of preneoplastic and neoplastic lesions of the oral cavity]. Minerva Stomatol (1997) 0.82
Endo-arterial regional injection of radioisotopes in the treatment of malignant tumours. Int J Appl Radiat Isot (1966) 0.81
The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol (2005) 0.81
Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. Leuk Res (2000) 0.81
Idarubicin in advanced breast cancer: a phase II study. Cancer Treat Rep (1986) 0.80
Malignant melanoma of soft tissues (clear cell sarcoma) of the foot. Is MRI able to perform a specific diagnosis? Report of one case and review of the radiological literature. Anticancer Res (2001) 0.80
Long-term postoperative results in 54 cases of early gastric cancer: the choice of surgical procedure. Eur J Surg Oncol (1989) 0.80
Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients. J Surg Oncol (2000) 0.80
[Immunologic study of patients with chronic pharyngitis]. Acta Otorhinolaryngol Ital (1990) 0.80
Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin. Breast Cancer Res Treat (2000) 0.80
Merkel cell carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease: review of clinical cases. Anticancer Res (1997) 0.80
[Study on the attitude and smoking habits of the students of a school for professional nurses]. Minerva Med (1988) 0.79
Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery. Surgery (1994) 0.79
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience. Anticancer Res (2000) 0.79
Regeneration of mandibular osteoradionecrosis defect with platelet rich plasma gel. In Vivo (2010) 0.79
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study. Eur J Cancer (1990) 0.79
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy. J Chemother (1990) 0.79
Randomized cooperative study of perioperative chemotherapy in breast cancer. J Clin Oncol (1995) 0.79
Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol (2001) 0.79
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity. Am J Clin Oncol (1993) 0.79
Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol (2000) 0.78
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. Eur J Cancer Clin Oncol (1985) 0.78
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. Haematologica (2001) 0.78
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancer. Acta Med Austriaca (1989) 0.78
Combined craniofacial approach to facial tumours involving the anterior skull base. Eur J Surg Oncol (1996) 0.78
Solitary fibrous tumor of the inguinal region: a clinicopathological, light-microscopic, immunohistochemical, electron microscopic and flow-cytometric DNA study. Anticancer Res (2002) 0.78
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer. Gynecol Oncol (1985) 0.78
Factors influencing local recurrence after curative surgery for rectal cancer. Oncology (1989) 0.78
Antitumoral activity of human fibroblast interferon administered intranodularly. Oncology (1985) 0.78
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol (1997) 0.78
A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. Adv Exp Med Biol (1988) 0.78